academic article

• Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials..  Leukemia & lymphoma.  59:1624-1633. 2018
• MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A children's oncology group study..  Leukemia.  :-. 2016
• Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. 2015
• Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232..  Blood.  :-. 2015
• A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. 2015
• Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014
• Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project..  Blood.  121:485-488. 2013
• Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  26:4376-4384. 2008